Clinical Trials

Enhancing Intergenerational Health in Nigeria: Peripartum as Critical Life Stage for Cardiovascular Health

Tuesday, January 14, 2025 12:00 AM

Conditions: Hypertension in Pregnancy; Hypertension; Obesity and Overweight; Maternal Morbidity and Mortality; Maternal and Child Health Outcomes Interventions: Behavioral: PAT+HEALTH curriculum - Nigeria Sponsors: Washington University ...

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

Tuesday, January 14, 2025 12:00 AM

Conditions: Diffuse Midline Glioma; Diffuse Midline High-grade Glioma; Medulloblastoma; Ependymoma Interventions: Biological: PEP-CMV vaccine; Biological: Tetanus booster; Biological: Nivolumab; Drug: Temozolomide Sponsors: Washington ...

64Cu-LLP2A for Imaging Hematologic Malignancies

Thursday, January 2, 2025 12:00 AM

Conditions: Multiple Myeloma; Low-Grade Lymphoma; Follicular Lymphoma; Marginal Zone Lymphoma; Lymphoplasmacytic Lymphoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia Interventions: Drug: 64Cu-LLP2A; Device: PET/CT Sponsors: ...

Parenting Intervention for Mothers With Substance Use Disorder

Tuesday, January 7, 2025 12:00 AM

Conditions: Substance Use Disorders; Children of Mothers With Substance Use Disorders Interventions: Behavioral: THRIVE Sponsors: Boston Medical Center; Washington University School of Medicine Recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Tuesday, January 14, 2025 12:00 AM

Conditions: Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer Interventions: Drug: Zumsemetinib; Drug: Capecitabine; Drug: Zoledronic acid; Drug: Denosumab Sponsors: Washington University School of Medicine; United States ...

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

Wednesday, January 8, 2025 12:00 AM

Conditions: Lung Cancer; Oligometastatic Lung Tumor Interventions: Radiation: One fraction stereotactic body radiotherapy; Device: HyperSight; Device: Ethos Sponsors: Washington University School of Medicine; Varian Medical Systems Recruiting

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Tuesday, January 14, 2025 12:00 AM

Conditions: Post-transplant Lymphoproliferative Disorder Interventions: Drug: Polatuzumab vedotin; Drug: Rituximab; Drug: CHP Sponsors: Washington University School of Medicine Recruiting

Sex Hormones, Postoperative Pain and Opioid Use

Tuesday, January 14, 2025 12:00 AM

Conditions: Postoperative Pain; Opioid Use Interventions: Behavioral: Pain; Behavioral: Opioid use Sponsors: Washington University School of Medicine Recruiting